4Indexed trials
drug · Product Intelligence
Venlafaxine
Pipeline Intelligence
Venlafaxine: 4 indexed trials, 4 sponsors; 1 linked Orange Book patents and 9 FDA-linked events where matched.
4Sponsors
1Orange Book patent links
9FDA-linked events
Development evidence
NCT00177671University of Pittsburgh · alzheimersPHASE4
NCT00211809Icahn School of Medicine at Mount Sinai · other_psychiatryPHASE4
NCT01658228New York State Psychiatric Institute · depressionPHASE4
NCT02086929Aziende Chimiche Riunite Angelini Francesco S.p.A · depressionPHASE3
FDA / patent evidence
7776358VENLAFAXINE BESYLATE · app 2154292028-05-16
Regulatory context
FDA_APPROVALVENLAFAXINE HYDROCHLORIDE · 2024-06-06
FDA_APPROVALVENLAFAXINE HYDROCHLORIDE · 2023-05-18
FDA_APPROVALVENLAFAXINE BESYLATE · 2022-06-29
FDA_APPROVALVENLAFAXINE HYDROCHLORIDE · 2021-01-21
FDA_APPROVALVENLAFAXINE HYDROCHLORIDE · 2018-11-23
FDA_APPROVALVENLAFAXINE HYDROCHLORIDE · 2011-04-15
FDA_APPROVALVENLAFAXINE HYDROCHLORIDE · 2010-08-04
FDA_APPROVALVENLAFAXINE HYDROCHLORIDE · 2008-06-13
FDA_APPROVALVENLAFAXINE HYDROCHLORIDE · 2006-08-03
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.